日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intrinsic p53 activation restricts gammaherpesvirus driven germinal center B cell expansion during latency establishment.

内在的 p53 激活限制了 γ 疱疹病毒驱动的生发中心 B 细胞在潜伏期建立过程中的扩增

Owens Shana M, Sifford Jeffrey M, Li Gang, Murdock Steven J, Salinas Eduardo, Oldenburg Darby, Ghosh Debopam, Stumhofer Jason S, Nookaew Intawat, Manzano Mark, Forrest J Craig

Trajectories of Pontine Volume in Patients with Multiple System Atrophy

多系统萎缩患者脑桥体积的变化轨迹

Kawabata, Kazuya; Krismer, Florian; Ito, Mizuki; Hara, Kazuhiro; Bagarinao, Epifanio; Beliveau, Vincent; Péran, Patrice; Arribarat, Germain; Traon, Anne Pavy-Le; Meissner, Wassilios G; Foubert-Samier, Alexandra; Fabbri, Margherita; Gordon, Mark Forrest; Ogura, Aya; Katsuno, Masahisa; Rascol, Olivier; Scherfler, Christoph; Seppi, Klaus; Watanabe, Hirohisa; Poewe, Werner

Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington Disease

在ARC-HD研究中,高剂量与低剂量氘代丁苯那嗪治疗亨廷顿舞蹈症的安全性和有效性比较

Frank, Samuel; Testa, Claudia M; Goldstein, Jody; Kayson, Elise; Leavitt, Blair R; Oakes, David; O'Neill, Christine; Whaley, Jacquelyn; Gross, Nicholas; Chaijale, Nayla; Barash, Steve; Gordon, Mark Forrest

Co-Designed Digital Device for Tracking Rehabilitation Dosage in a Clinical Environment After Stroke: Mixed Methods Validity and Feasibility Study

用于在临床环境中追踪中风后康复剂量的协同设计数字设备:混合方法有效性和可行性研究

Boyd, Fiona; Sweeney, Gillian; Barber, Mark; Forrest, Elaine; Dunlop, Mark; Kerr, Andrew

Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease

氘代丁苯那嗪治疗亨廷顿病相关迟发性运动障碍和舞蹈症的安全性

Frank, Samuel; Anderson, Karen E; Fernandez, Hubert H; Hauser, Robert A; Claassen, Daniel O; Stamler, David; Factor, Stewart A; Jimenez-Shahed, Joohi; Barkay, Hadas; Wilhelm, Amanda; Alexander, Jessica K; Chaijale, Nayla; Barash, Steve; Savola, Juha-Matti; Gordon, Mark Forrest; Chen, Maria

Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease

更正:氘代丁苯那嗪治疗亨廷顿病相关迟发性运动障碍和舞蹈症的安全性

Frank, Samuel; Anderson, Karen E; Fernandez, Hubert H; Hauser, Robert A; Claassen, Daniel O; Stamler, David; Factor, Stewart A; Jimenez-Shahed, Joohi; Barkay, Hadas; Wilhelm, Amanda; Alexander, Jessica K; Chaijale, Nayla; Barash, Steve; Savola, Juha-Matti; Gordon, Mark Forrest; Chen, Maria

A PET-CT study on neuroinflammation in Huntington's disease patients participating in a randomized trial with laquinimod

一项针对亨廷顿病患者神经炎症的PET-CT研究,这些患者参与了一项使用拉喹莫德的随机试验。

Roussakis, Andreas-Antonios; Gennaro, Marta; Gordon, Mark Forrest; Reilmann, Ralf; Borowsky, Beth; Rynkowski, Gail; Lao-Kaim, Nicholas P; Papoutsou, Zoe; Savola, Juha-Matti; Hayden, Michael R; Owen, David R; Kalk, Nicola; Lingford-Hughes, Anne; Gunn, Roger N; Searle, Graham; Tabrizi, Sarah J; Piccini, Paola

Is the association between blood pressure and cognition in the oldest-old modified by physical, vascular or brain pathology markers? The EMIF-AD 90 + Study

血压与认知能力在老年人群中的关联是否会受到生理、血管或脑部病理标志物的影响?EMIF-AD 90+ 研究

Legdeur, Nienke; Moonen, Justine E; Badissi, Maryam; Sudre, Carole H; Pelkmans, Wiesje; Gordon, Mark Forrest; Barkhof, Frederik; Peters, Mike; Visser, Pieter Jelle; Muller, Majon

Sensitivity to Change and Patient-Centricity of the Unified Multiple System Atrophy Rating Scale Items: A Data-Driven Analysis

统一多系统萎缩评定量表条目对变化的敏感性和以患者为中心的性:一项数据驱动分析

Krismer, Florian; Seppi, Klaus; Jönsson, Linus; Åström, Daniel Oudin; Berger, Anna-Karin; Simonsen, Jacob; Gordon, Mark Forrest; Wenning, Gregor K; Poewe, Werner

Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study

长期使用氘代丁苯那嗪治疗迟发性运动障碍可带来持续的益处和安全性:一项为期 3 年的开放标签扩展研究

Hauser, Robert A; Barkay, Hadas; Fernandez, Hubert H; Factor, Stewart A; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Wilhelm, Amanda; Alexander, Jessica; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E